Alx Oncology Holdings (ALXO) Return on Sales (2019 - 2021)

Alx Oncology Holdings' Return on Sales history runs 3 years deep, the most recent figure standing at 0.35% for Q1 2021.

• In Q1 2021, Return on Sales fell 27.0% year-over-year to 0.35%; the TTM figure through Mar 2021 stood at 0.35% (down 30.0% YoY), while the FY2020 annual figure was 0.08%, down 4.0% from the prior year.
• Return on Sales came in at 0.35% for Q1 2021 at Alx Oncology Holdings, down from 0.08% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.02% in Q3 2019 to a low of 0.35% in Q1 2021.
• A 3-year average of 0.13% and a median of 0.08% in 2020 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales retreated 1 bps in 2020 and dropped 27 bps in 2021, its largest moves.
• Alx Oncology Holdings' Return on Sales stood at 0.07% in 2019, then declined by 16 bps to 0.08% in 2020, then tumbled by 326 bps to 0.35% in 2021.
• According to Business Quant data, Return on Sales over the past three periods registered 0.35%, 0.08%, and 0.15% for Q1 2021, Q4 2020, and Q3 2020 respectively.

Peer Comparison